Editorial: Paradoxical Skin Lesions During Anti-TNF Treatment-An Additional Argument to Consider New Biologics as First-Line Therapy in Inflammatory Bowel Disease. Authors’ Reply

Alimentary Pharmacology and Therapeutics - United Kingdom

doi 10.1111/apt.14917